Clinical Trials Logo

Heart Defects, Congenital clinical trials

View clinical trials related to Heart Defects, Congenital.

Filter by:

NCT ID: NCT01501786 Completed - Clinical trials for Congenital Heart Disease

Does Ketamine Attenuate Depression of Respiratory and Cardiac Functions

Start date: January 2012
Phase: N/A
Study type: Interventional

Normal cardiac and respiratory functions should be maintained during pediatric cardiac catheterization. Propofol has become a popular choice for sedation in children, however, it depresses cardiac and respiratory functions. Some investigators reported that ketamine attenuates its depressant effect, but it remains unclear whether ketamine reduces cardiac and respiratory depression caused by propofol in pediatric cardiac catheterization.

NCT ID: NCT01489475 Completed - Clinical trials for Congenital Heart Defects

Plasma Angiopoietin Levels in Children Following Cardiopulmonary Bypass

Start date: November 2011
Phase: N/A
Study type: Observational

During cardiopulmonary bypass (CPB) after heart surgery, a child's blood is exposed to many foreign entities. These conditions trigger the body's inflammatory response which results in leaky capillaries, increased swelling and possibly organ dysfunction. Since the early 1990's, modified ultrafiltration (MUF) has been shown to decrease excess swelling, reduce bleeding, improve heart function, and decrease hospital length of stay. Angiopoietins are a family of proteins necessary for both normal and abnormal blood vessel formation. They also appear to play a role in capillary leak. Though MUF has been shown to improve clinical outcome following CPB, there continues to be conflicting reports whether this is a result of the filtration of inflammatory proteins or simply from excess fluid removal. Since angiopoietins appear to play a role in both inflammation and capillary leak, the investigators hypothesize that the benefit seen after MUF is also secondary to its ability to filter out these proteins, especially angiopoietin-2.

NCT ID: NCT01484886 Completed - Clinical trials for Congenital Heart Disease

Restrictive Versus Liberal Transfusion Protocol in Infants Undergoing Cardiac Surgery

Start date: January 2012
Phase: N/A
Study type: Interventional

In neonates and infants </= 10 kg following cardiac surgery for congenital heart disease a more restrictive red blood cell (RBC) transfusion strategy will be as effective as, and possibly superior to, a liberal RBC strategy. Allowing lower hemoglobin concentration will not affect the cardiac or pulmonary status of the patient.

NCT ID: NCT01479049 Completed - Clinical trials for Congenital Heart Disease

The Myocardial Protective Effects of a Moderate-potassium Blood Cardioplegia in Pediatric Cardiac Surgery

Start date: October 2009
Phase: N/A
Study type: Interventional

The investigators previously investigated the cardioprotective effect of an adenosine-lidocaine cardioplegia with moderate-potassium (K+, 10.0 mmol/L) in pediatric cardiac surgery, which was associated with better myocardial protective effects when compared with conventional high-potassium cardioplegia. However, this cardioplegia could not be sucked back into the cardiopulmonary bypass (CPB) circuit because of excessive hemodilution and severe systemic hypotension induced by adenosine. Therefore, the investigators supposed that a moderate-potassium (K+, 10.0 mmol/L) blood cardioplegia without adenosine could also arrest the heart and have better myocardial protective effects compared with conventional hyperkalamic cold blood cardioplegia during cardiac operations without excessive hemodilution and systemic hypotension.

NCT ID: NCT01475357 Completed - Clinical trials for Congenital Heart Defects

Intestinal Function in Neonates With Complex Congenital Heart Disease

Start date: October 2011
Phase: N/A
Study type: Interventional

Postnatal intestinal function in cardiac infants. The overall goal of this proposal is to address a widespread health problem in the pediatric cardiac infant population - poor postnatal growth - through a collaborative effort between pediatric cardiology, cardiothoracic surgery, neonatology, microbiology, and immunology. The hypothesis is that term neonates with complex congenital heart disease (CHD) who receive trophic breastmilk feeds in the pre-operative period will show improved gut function than neonates who were strictly NPO (nothing by mouth) in the pre-operative period.

NCT ID: NCT01460316 Completed - Clinical trials for Conotruncal Cardiac Defects

Conotruncal Cardiac Defects and Nutrigenetic Etiopathogeny

CCOMET
Start date: October 2011
Phase: N/A
Study type: Observational

The investigators planned to study the etiopathogenic factors of conotruncal cardiac defects regarding the relations between the metabolic, the genetic and the environmental factors which lead to these cardiopathy.

NCT ID: NCT01426542 Completed - Clinical trials for Cyanotic Congenital Heart Disease

Preventing Brain Injury in Infants With Congenital Heart Disease

Start date: March 2011
Phase: Phase 1
Study type: Interventional

Newborn babies with congenital heart disease often require surgery in the first month of life. The risks of brain damage from congenital heart disease and from the various corrective surgeries are high because of poor levels of oxygen reaching the brain. Topiramate is an anti-convulsant medication that protects brain cells from damage due to low amounts of oxygen in animal studies. The investigators hypothesize that giving topiramate to babies with congenital heart disease before and after surgery will decrease the amount of brain damage caused by the heart disease and/or the surgery to correct the heart disease.

NCT ID: NCT01397526 Completed - Clinical trials for Heart Defects, Congenital

Colloid Osmotic Pressure During Heart Surgery in Children

Start date: July 2011
Phase: N/A
Study type: Observational

Clinical oedema is seen after open heart surgery with the use of cardiopulmonary bypass and hypothermia in children. The oedema formation is due to increased fluid transport from blood to tissue. This transcapillary fluid transport is dependent on differences in interstitial and plasma colloid osmotic pressure. The purpose of this investigation is to evaluate changes in interstitial colloid osmotic pressure before, under and after the use of cardiopulmonary bypass in children. The study hypothesis is that oedema developed during cardiopulmonary bypass and hypothermia is caused by increased micro vascular protein leakage and reduced colloid osmotic pressure gradient through the capillary membrane.

NCT ID: NCT01368705 Completed - Clinical trials for Congenital Heart Disease

Nitrogen Balance in Infants After Post Cardiothoracic Surgery

Start date: August 2009
Phase: Phase 4
Study type: Interventional

The objective is to the amount of protein infants require after cardiopulmonary bypass surgery.

NCT ID: NCT01353287 Completed - Clinical trials for Aortic Valve Disorder

Transcatheter Aortic Valve Intervention-Live Transmission

VERITAS
Start date: May 2011
Phase: N/A
Study type: Observational

The primary objective of this clinical trial is to evaluate safety of patients who underwent Transcatheter Aortic Valve Intervention (TAVI) during a live case or video-taped transmission as compared to those without procedure transmission.